HF
VRTX icon

HRT Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

HRT Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,500
Closed -$3.52M – 3803
2022
Q1 		$3.52M Buy
+13,500
New +$3.2M 0.03% 393

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HRT Financial's VRTX Position: Q1 2026 in Review

HRT Financial opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 26,790 shares worth $12M. The stake represents 0.03% of the portfolio and ranks #551 among its holdings. This is a return to the name: HRT Financial previously reported a position in VRTX as recently as Q4 2024.

HRT Financial first reported a position in VRTX in Q3 2015 and has held it in 15 quarters since. The position peaked at $57.9M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • HRT Financial held 26,790 shares of Vertex Pharmaceuticals worth $12M as of Q1 2026.
  • Vertex Pharmaceuticals was a new HRT Financial position in Q1 2026.
  • Vertex Pharmaceuticals made up 0.03% of HRT Financial's portfolio in Q1 2026, its #551 holding.
  • HRT Financial first reported a position in Vertex Pharmaceuticals in Q3 2015 and has held it in 15 quarters since.
  • HRT Financial's Vertex Pharmaceuticals position peaked at $57.9M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.